8/12/24 16:30 | 8/8/24 | LNSR | Lensar, Inc. | DE | Health | MdEq | Surgical & Medical Instrument | Staab Thomas R II | FL | O | CFO | M.d | 9 | 2.65 | 0 | 4 | 2 | 162 | D | | | | | | | | | | | | | | |
12/7/22 21:26 | 12/6/22 | LNSR | Lensar, Inc. | DE | Health | MdEq | Surgical & Medical Instrument | Staab Thomas R II | FL | O | CFO | P.m | 9 | 3.16 | 0 | 3 | 2 | 135 | D | | | | | | | | | | | | | | |
5/20/19 16:21 | 5/16/19 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | M.d | 7 | 1.42 | 0 | 5 | 4 | 125 | D | | | | | | | | | | | | | | |
5/20/19 16:21 | 5/16/19 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | S.dm | -75 | 7.65 | 0 | -10 | -7 | 125 | D | | | | | | | | | | | | | | |
5/16/19 16:29 | 5/14/19 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | M.dm | 13 | 1.42 | 0 | 9 | 8 | 130 | D | | | | | | | | | | | | | | |
5/16/19 16:29 | 5/14/19 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | S.dm | -92 | 7.81 | 0 | -12 | -8 | 130 | D | | | | | | | | | | | | | | |
5/13/19 16:57 | 5/9/19 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | M.dm | 107 | 5.51 | 0 | 20 | 17 | 133 | D | | | | | | | | | | | | | | |
5/13/19 16:57 | 5/9/19 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | S.dm | -150 | 7.70 | 0 | -20 | -13 | 133 | D | | | | | | | | | | | | | | |
5/6/19 16:51 | 5/2/19 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | M.dm | 92 | 5.51 | 0 | 17 | 14 | 133 | D | | | | | | | | | | | | | | |
5/6/19 16:51 | 5/2/19 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | S.dm | -126 | 7.54 | 0 | -17 | -11 | 133 | D | | | | | | | | | | | | | | |
4/8/19 14:30 | 4/4/19 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | M.d | 41 | 5.51 | 0 | 8 | 6 | 133 | D | | | | | | | | | | | | | | |
4/8/19 14:30 | 4/4/19 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | S.d | -66 | 8.81 | 0 | -8 | -5 | 133 | D | | | | | | | | | | | | | | |
1/30/19 16:10 | 1/28/19 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | M.d | 27 | 5.45 | 0 | 5 | 4 | 128 | D | | | | | | | | | | | | | | |
1/30/19 16:10 | 1/28/19 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | S.d | -49 | 9.85 | 0 | -5 | -4 | 128 | D | | | | | | | | | | | | | | |
12/6/18 16:30 | 12/4/18 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | S | -37 | 9.45 | 0 | -4 | -3 | 133 | D | | | | | | | | | | | | | | |
11/21/18 16:48 | 11/19/18 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | M.dm | 39 | 3.45 | 0 | 11 | 9 | 137 | D | | | | | | | | | | | | | | |
11/21/18 16:48 | 11/19/18 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | S.dm | -97 | 8.67 | 0 | -11 | -8 | 137 | D | | | | | | | | | | | | | | |
11/9/18 16:14 | 11/7/18 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | M.dm | 47 | 3.31 | 0 | 14 | 11 | 137 | D | | | | | | | | | | | | | | |
11/9/18 16:14 | 11/7/18 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | S.dm | -114 | 8.12 | 0 | -14 | -9 | 137 | D | | | | | | | | | | | | | | |
11/7/18 16:03 | 11/5/18 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | M.d | 1 | 3.22 | 0 | 0 | 0 | 137 | D | | | | | | | | | | | | | | |
11/7/18 16:03 | 11/5/18 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | S.d | -2 | 8.00 | 0 | 0 | 0 | 137 | D | | | | | | | | | | | | | | |
11/6/18 16:04 | 11/2/18 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | M.d | 37 | 3.40 | 0 | 11 | 9 | 137 | D | | | | | | | | | | | | | | |
11/6/18 16:04 | 11/2/18 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | S.d | -85 | 7.84 | 0 | -11 | -7 | 137 | D | | | | | | | | | | | | | | |
10/23/18 13:34 | 10/19/18 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | M.d | 12 | 3.78 | 0 | 3 | 2 | 137 | D | | | | | | | | | | | | | | |
10/23/18 13:34 | 10/19/18 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | S.d | -23 | 7.45 | 0 | -3 | -2 | 137 | D | | | | | | | | | | | | | | |
10/4/18 13:09 | 10/2/18 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | M.dm | 34 | 3.41 | 0 | 10 | 8 | 137 | D | | | | | | | | | | | | | | |
10/4/18 13:09 | 10/2/18 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | S.dm | -71 | 7.24 | 0 | -10 | -7 | 137 | D | | | | | | | | | | | | | | |
5/24/17 16:33 | 5/22/17 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | M.d | 37 | 4.73 | 0 | 8 | 6 | 142 | D | | | | | | | | | | | | | | |
3/22/17 10:40 | 3/20/17 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | M.d | 12 | 3.78 | 24 | 3 | 2 | 141 | D | -13 | 200 | 83 | 34 | 46 | 21 | -7 | -6 | 3 | 4 | -20 | | | |
3/22/17 10:40 | 3/20/17 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | S.d | -30 | 9.20 | 24 | -3 | -2 | 141 | D | -13 | 200 | 83 | 34 | 46 | 21 | -7 | -6 | 3 | 4 | -20 | | | |
3/20/17 15:01 | 3/16/17 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | M.d | 108 | 2.97 | 24 | 36 | 35 | 141 | D | -12 | 242 | 96 | 61 | 53 | 61 | 5 | 6 | 4 | -1 | -25 | | | |
3/14/17 13:47 | 3/10/17 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | M.d | 12 | 3.78 | 23 | 3 | 3 | 117 | D | -10 | 204 | 99 | 52 | 42 | 41 | 16 | 2 | -3 | 7 | -16 | | | |
3/14/17 13:47 | 3/10/17 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | S.d | -29 | 9.06 | 23 | -3 | -3 | 117 | D | -10 | 204 | 99 | 52 | 42 | 41 | 16 | 2 | -3 | 7 | -16 | | | |
3/10/17 16:19 | 3/8/17 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | M.d | 25 | 3.78 | 19 | 7 | 6 | 117 | D | -9 | 217 | 85 | 55 | 36 | 33 | 40 | 12 | -3 | -1 | -19 | | | |
3/10/17 16:19 | 3/8/17 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | S.d | -55 | 8.43 | 19 | -7 | -5 | 117 | D | -9 | 217 | 85 | 55 | 36 | 33 | 40 | 12 | -3 | -1 | -19 | | | |
3/8/17 08:05 | 3/6/17 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | M.d | 12 | 3.78 | 17 | 3 | 3 | 117 | D | -23 | 160 | 85 | 41 | 24 | 34 | 41 | 5 | 8 | 8 | -3 | | | |
3/8/17 08:05 | 3/6/17 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | S.d | -26 | 7.90 | 17 | -3 | -3 | 117 | D | -23 | 160 | 85 | 41 | 24 | 34 | 41 | 5 | 8 | 8 | -3 | | | |
12/21/16 10:42 | 12/19/16 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | M.d | 12 | 3.78 | 6 | 3 | 3 | 124 | D | -38 | -37 | 145 | 47 | 47 | 23 | 25 | 24 | -4 | -4 | -14 | 23 | | |
12/21/16 10:42 | 12/19/16 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | S.d | -24 | 7.45 | 6 | -3 | -3 | 124 | D | -38 | -37 | 145 | 47 | 47 | 23 | 25 | 24 | -4 | -4 | -14 | 23 | | |
8/15/16 14:07 | 8/11/16 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | S.m | -30 | 5.18 | 6 | -6 | -5 | 124 | D | -64 | -56 | 195 | 73 | 71 | 66 | 25 | 2 | -6 | -14 | -16 | 1 | 16 | |
8/11/16 13:53 | 8/9/16 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | S | -65 | 4.43 | 4 | -15 | -10 | 130 | D | -63 | -56 | 178 | 77 | 72 | 68 | 35 | 21 | 1 | -14 | -13 | -7 | 20 | |
1/21/16 11:04 | 1/19/16 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | M.d | 27 | 1.81 | 6 | 15 | 11 | 150 | D | -30 | -32 | -53 | -13 | -26 | -30 | -11 | -1 | -7 | -7 | -73 | -59 | -61 | -20 |
12/22/15 15:45 | 12/21/15 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | S | -33 | 10.86 | 8 | -3 | -2 | 137 | D | 56 | -2 | -29 | -13 | 8 | 2 | 7 | 5 | -3 | -1 | -32 | -76 | -74 | -37 |
12/18/15 14:54 | 12/17/15 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | S | -31 | 10.49 | 6 | -3 | -2 | 140 | D | 59 | -6 | -34 | -23 | 8 | 0 | 0 | 6 | 0 | 4 | -27 | -73 | -72 | -40 |
7/22/15 17:21 | 7/20/15 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | S | -58 | 16.50 | 16 | -4 | -2 | 143 | D | 555 | 43 | 44 | 51 | 25 | 8 | 4 | 0 | -1 | 0 | -24 | -43 | -50 | -79 |
6/24/15 16:57 | 6/22/15 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | M.d | 18 | 4.73 | 15 | 4 | 3 | 146 | D | 909 | 27 | 37 | 74 | 44 | 24 | 21 | 5 | 1 | 4 | 8 | -12 | -23 | -76 |
6/24/15 16:57 | 6/22/15 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | S.d | -60 | 16.00 | 15 | -4 | -3 | 146 | D | 909 | 27 | 37 | 74 | 44 | 24 | 21 | 5 | 1 | 4 | 8 | -12 | -23 | -76 |
6/22/15 16:38 | 6/18/15 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | S.dm | -235 | 14.36 | 13 | -16 | -10 | 146 | D | 813 | 34 | 43 | 64 | 55 | 32 | 22 | 23 | -3 | -7 | 2 | -16 | -35 | -83 |
6/22/15 16:38 | 6/18/15 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | M.dm | 35 | 3.78 | 13 | 9 | 7 | 146 | D | 813 | 34 | 43 | 64 | 55 | 32 | 22 | 23 | -3 | -7 | 2 | -16 | -35 | -83 |
6/9/15 13:33 | 6/5/15 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | S | -77 | 12.75 | 8 | -6 | -4 | 153 | D | 690 | 19 | 31 | 36 | 31 | 19 | 17 | 6 | -1 | -5 | 15 | -12 | -17 | -71 |
6/2/15 14:57 | 6/1/15 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | S | -36 | 12.00 | 7 | -3 | -2 | 159 | D | 586 | 19 | 4 | 15 | 15 | 15 | 4 | 5 | 1 | 10 | 26 | -4 | -13 | -71 |
5/19/15 16:53 | 5/18/15 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | S | -33 | 11.00 | 7 | -3 | -2 | 162 | D | 535 | 32 | 6 | 8 | 14 | 14 | 16 | 7 | 2 | 1 | 18 | 9 | -14 | -74 |
12/31/14 14:09 | 12/29/14 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | M.d | 36 | 3.78 | 11 | 10 | 6 | 163 | D | 765 | 59 | -7 | 24 | 20 | 18 | 9 | 2 | 0 | 0 | -16 | -18 | 20 | -13 |
12/31/14 14:09 | 12/29/14 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | S.d | -119 | 12.56 | 11 | -10 | -6 | 163 | D | 765 | 59 | -7 | 24 | 20 | 18 | 9 | 2 | 0 | 0 | -16 | -18 | 20 | -13 |
8/29/14 11:04 | 8/27/14 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | M.d | 55 | 5.45 | 19 | 10 | 7 | 163 | D | 237 | 102 | 13 | 33 | 17 | -5 | -1 | 0 | 2 | -7 | -21 | -14 | -22 | -14 |
8/29/14 11:04 | 8/27/14 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | S.d | -136 | 13.58 | 19 | -10 | -6 | 163 | D | 237 | 102 | 13 | 33 | 17 | -5 | -1 | 0 | 2 | -7 | -21 | -14 | -22 | -14 |
7/28/14 13:21 | 7/25/14 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | M.d | 100 | 3.78 | 16 | 26 | 19 | 162 | D | 170 | 155 | 1 | 47 | 4 | -3 | 6 | 1 | 0 | 7 | 12 | 4 | -4 | 28 |
7/2/14 16:33 | 7/1/14 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | M.d | 15 | 4.73 | 20 | 3 | 2 | 144 | D | 230 | 709 | 70 | 19 | 53 | 11 | 10 | 5 | -1 | -8 | -3 | -24 | -6 | 13 |
7/2/14 16:33 | 7/1/14 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | S.d | -41 | 13.00 | 20 | -3 | -2 | 144 | D | 230 | 709 | 70 | 19 | 53 | 11 | 10 | 5 | -1 | -8 | -3 | -24 | -6 | 13 |
6/24/14 15:41 | 6/23/14 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | M.d | 15 | 4.73 | 19 | 3 | 2 | 144 | D | 213 | 695 | 72 | 18 | 56 | 22 | 6 | 1 | 0 | 6 | 1 | -13 | -7 | 27 |
6/24/14 15:41 | 6/23/14 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | S.d | -39 | 12.49 | 19 | -3 | -2 | 144 | D | 213 | 695 | 72 | 18 | 56 | 22 | 6 | 1 | 0 | 6 | 1 | -13 | -7 | 27 |
6/19/14 16:47 | 6/17/14 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | M.d | 15 | 4.73 | 17 | 3 | 2 | 144 | D | 225 | 564 | 86 | 5 | 39 | 16 | 5 | 5 | 2 | 5 | -3 | -3 | -12 | 24 |
6/19/14 16:47 | 6/17/14 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | S.d | -38 | 12.00 | 17 | -3 | -2 | 144 | D | 225 | 564 | 86 | 5 | 39 | 16 | 5 | 5 | 2 | 5 | -3 | -3 | -12 | 24 |
5/27/14 16:03 | 5/22/14 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | M.d | 67 | 3.78 | 5 | 18 | 14 | 144 | D | 165 | 443 | 64 | -22 | 1 | 2 | 5 | 6 | -1 | -7 | 20 | 30 | 2 | 13 |
3/17/14 14:52 | 3/14/14 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | M.d | 15 | 4.73 | 15 | 3 | 3 | 127 | D | 100 | 742 | 79 | 94 | 9 | -4 | -13 | 3 | -4 | -3 | -26 | 2 | 7 | -9 |
3/17/14 14:52 | 3/14/14 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | S.d | -35 | 11.24 | 15 | -3 | -2 | 127 | D | 100 | 742 | 79 | 94 | 9 | -4 | -13 | 3 | -4 | -3 | -26 | 2 | 7 | -9 |
3/7/14 16:02 | 3/4/14 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | M.d | 14 | 4.73 | 14 | 3 | 2 | 127 | D | 162 | 901 | 85 | 102 | 1 | 23 | -4 | -1 | 0 | -4 | -19 | -7 | 11 | -11 |
3/7/14 16:02 | 3/4/14 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | S.d | -38 | 12.69 | 14 | -3 | -2 | 127 | D | 162 | 901 | 85 | 102 | 1 | 23 | -4 | -1 | 0 | -4 | -19 | -7 | 11 | -11 |
1/15/14 08:51 | 1/13/14 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Staab Thomas R II | NC | O | SVP,CFO | M.d | 133 | 3.78 | 12 | 35 | 95 | 72 | D | 355 | 504 | 494 | 73 | 81 | 59 | 35 | 15 | -4 | 6 | -13 | -27 | -3 | 0 |
3/14/07 11:59 | 3/12/07 | ISPH | Inspire Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Staab Thomas R II | NC | O | CFO,Trea | M.d | 11 | 5.25 | 0 | 2 | 10 | 22 | D | | | | | | | | | | | | | | |